BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Arora P, Wu C, Hamid T, Arora G, Agha O, Allen K, Tainsh RET, Hu D, Ryan RA, Domian IJ, Buys ES, Bloch DB, Prabhu SD, Bloch KD, Newton-Cheh C, Wang TJ. Acute Metabolic Influences on the Natriuretic Peptide System in Humans. J Am Coll Cardiol 2016;67:804-12. [PMID: 26892417 DOI: 10.1016/j.jacc.2015.11.049] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Hou K, Shen J, Yan J, Zhai C, Zhang J, Pan JA, Zhang Y, Jiang Y, Wang Y, Lin RZ, Cong H, Gao S, Zong WX. Loss of TRIM21 alleviates cardiotoxicity by suppressing ferroptosis induced by the chemotherapeutic agent doxorubicin. EBioMedicine 2021;69:103456. [PMID: 34233258 DOI: 10.1016/j.ebiom.2021.103456] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Patel N, Russell GK, Musunuru K, Gutierrez OM, Halade G, Kain V, Lv W, Prabhu SD, Margulies KB, Cappola TP, Arora G, Wang TJ, Arora P. Race, Natriuretic Peptides, and High-Carbohydrate Challenge: A Clinical Trial. Circ Res 2019;125:957-68. [PMID: 31588864 DOI: 10.1161/CIRCRESAHA.119.315026] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 5.3] [Reference Citation Analysis]
3 Rubattu S, Stanzione R, Cotugno M, Bianchi F, Marchitti S, Forte M. Epigenetic control of natriuretic peptides: implications for health and disease. Cell Mol Life Sci 2020;77:5121-30. [DOI: 10.1007/s00018-020-03573-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Parcha V, Patel N, Musunuru K, Margulies KB, Cappola TP, Halade G, Wang TJ, Arora G, Arora P. Natriuretic Peptide Deficiency in Obese Individuals: Mechanistic Insights From Healthy Organ Donor Cohort. J Am Coll Cardiol 2021;77:3138-40. [PMID: 34140113 DOI: 10.1016/j.jacc.2021.04.055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Mezzasoma L, Peirce MJ, Minelli A, Bellezza I. Natriuretic Peptides: The Case of Prostate Cancer. Molecules 2017;22:E1680. [PMID: 28994721 DOI: 10.3390/molecules22101680] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
6 Buckley LF, Carbone S, Aldemerdash A, Fatani N, Fanikos J. Novel and Emerging Therapeutics for Primary Prevention of Cardiovascular Disease. Am J Med 2019;132:16-24. [PMID: 30201240 DOI: 10.1016/j.amjmed.2018.08.019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
7 Verboven K, Hansen D, Jocken JWE, Blaak EE. Natriuretic peptides in the control of lipid metabolism and insulin sensitivity. Obes Rev 2017;18:1243-59. [PMID: 28901677 DOI: 10.1111/obr.12598] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
8 Asferg CL, Nielsen SJ, Andersen UB, Linneberg A, Goetze JP, Jeppesen JL. Serum proatrial natriuretic peptide concentrations during oral glucose-induced acute hyperinsulinemia in lean and obese men. Peptides 2019;111:98-102. [PMID: 29524563 DOI: 10.1016/j.peptides.2018.03.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
9 Zois NE, Terzic D, Færch K, Plomgaard P, Hansen JS, Rossing P, Goetze JP. Effect of Pancreatic Hormones on pro-Atrial Natriuretic Peptide in Humans. EBioMedicine 2017;17:88-94. [PMID: 28262549 DOI: 10.1016/j.ebiom.2017.02.026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
10 Thomsen CF, Goharian TS, Larsen KT, Goetze JP, Andersen LB, Jeppesen JL. Intensive Lifestyle Intervention Increases Plasma Midregional Proatrial Natriuretic Peptide Concentrations in Overweight Children. J Am Heart Assoc 2021;10:e020676. [PMID: 34180245 DOI: 10.1161/JAHA.121.020676] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Parcha V, Patel N, Gutierrez OM, Li P, Gamble KL, Musunuru K, Margulies KB, Cappola TP, Wang TJ, Arora G, Arora P. Chronobiology of Natriuretic Peptides and Blood Pressure in Lean and Obese Individuals. J Am Coll Cardiol 2021;77:2291-303. [PMID: 33958126 DOI: 10.1016/j.jacc.2021.03.291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Bachmann KN, Deger SM, Alsouqi A, Huang S, Xu M, Ferguson JF, Su YR, Niswender KD, Ikizler TA, Wang TJ. Acute effects of insulin on circulating natriuretic peptide levels in humans. PLoS One 2018;13:e0196869. [PMID: 29758041 DOI: 10.1371/journal.pone.0196869] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
13 Bai Y, Bao X, Jiang G, Ge D, He W, Zhao D, Zhang Y, Dong R, Hua J, Yang N, Mo F, Gao S. Jiang Tang Xiao Ke Granule Protects Hepatic Tissue of Diabetic Mice Through Modulation of Insulin and Ras Signaling - A Bioinformatics Analysis of MicroRNAs and mRNAs Network. Front Pharmacol 2020;11:173. [PMID: 32210802 DOI: 10.3389/fphar.2020.00173] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Ogawa M, Hori Y, Kanno N, Iwasa N, Toyofuku T, Isayama N, Yoshikawa A, Akabane R, Sakatani A, Miyakawa H, Hsu HH, Miyagawa Y, Takemura N. Comparison of N-terminal pro-atrial natriuretic peptide and three cardiac biomarkers for discriminatory ability of clinical stage in dogs with myxomatous mitral valve disease. J Vet Med Sci 2021;83:705-15. [PMID: 33551383 DOI: 10.1292/jvms.20-0629] [Reference Citation Analysis]
15 Sonne DP, Terzic D, Knop FK, Goetze JP. Postprandial Plasma Concentrations of ProANP in Patients with Type 2 Diabetes and Healthy Controls. Clinical Chemistry 2017;63:1040-1. [DOI: 10.1373/clinchem.2016.268060] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
16 Asferg CL, Andersen UB, Linneberg A, Goetze JP, Jeppesen JL. Obese Hypertensive Men Have Lower Circulating Proatrial Natriuretic Peptide Concentrations Despite Greater Left Atrial Size. Am J Hypertens 2018;31:645-50. [PMID: 29471357 DOI: 10.1093/ajh/hpy029] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
17 Barwari T, Skroblin P, Mayr M. When Sweet Turns Salty: Glucose-Induced Suppression of Atrial Natriuretic Peptide by MicroRNA-425. J Am Coll Cardiol 2016;67:813-6. [PMID: 26892418 DOI: 10.1016/j.jacc.2015.12.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
18 Tan NY, Deng Y, Yao X, Sangaralingham LR, Shah ND, Rule AD, Burnett JC Jr, Dunlay SM, Sangaralingham SJ. Renal Outcomes in Patients with Systolic Heart Failure Treated With Sacubitril-Valsartan or Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker. Mayo Clin Proc Innov Qual Outcomes 2021;5:286-97. [PMID: 33997628 DOI: 10.1016/j.mayocpiqo.2020.10.008] [Reference Citation Analysis]
19 Hollstein T, Schlicht K, Krause L, Hagen S, Rohmann N, Schulte DM, Türk K, Beckmann A, Ahrens M, Franke A, Schreiber S, Becker T, Beckmann J, Laudes M. Effect of various weight loss interventions on serum NT-proBNP concentration in severe obese subjects without clinical manifest heart failure. Sci Rep 2021;11:10096. [PMID: 33980890 DOI: 10.1038/s41598-021-89426-7] [Reference Citation Analysis]
20 Mark PD, Hunter I, Terzic D, Goetze JP. Processing-independent proANP measurement for low concentrations in plasma: reference intervals and effect of body mass index and plasma glucose. Clin Chem Lab Med 2017;56:132-7. [PMID: 28688223 DOI: 10.1515/cclm-2017-0309] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
21 Moro C. Does Insulin Resistance Trigger Natriuretic Peptide Deficiency? EBioMedicine 2017;17:11-2. [PMID: 28284816 DOI: 10.1016/j.ebiom.2017.03.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
22 Oi Y, Nagoshi T, Kimura H, Tanaka Y, Yoshii A, Yasutake R, Takahashi H, Kashiwagi Y, Tanaka TD, Tachibana T, Yoshimura M. Exogenous ANP Treatment Ameliorates Myocardial Insulin Resistance and Protects against Ischemia–Reperfusion Injury in Diet-Induced Obesity. IJMS 2022;23:8373. [DOI: 10.3390/ijms23158373] [Reference Citation Analysis]
23 Moro C. Targeting cardiac natriuretic peptides in the therapy of diabetes and obesity. Expert Opinion on Therapeutic Targets 2016;20:1445-52. [DOI: 10.1080/14728222.2016.1254198] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]